Powerful discount investment strategy in pre-IPO companies:
We invest in very late stage pre-IPO companies valued at over $1 billion with revenues generally over $100 million and first-class existing institutional investors. We aim to invest at a substantial discount to the last institutional round. Average discount as of Jan 2024 of our recent fund is almost 50% to the last institutional round.
Current portfolio company investments and holdings:
30+ portfolio companies including among others: Stripe (reached $95 billion+ valuation), Cityblock Health (reached $6 billion+ valuation), Rappi (reached $5 billion+ valuation), Salsify (reached $2 billion+ valuation), Tealium (reached $1 billion+ valuation), BigID (reached $1 billion+ valuation), Tradeshift (reached $1 billion+ valuation), Podium (reached $3 billion+ valuation), Aviatrix (reached $2 billion+ valuation), ThoughtSpot (reached $4 billion+ valuation), Cerebras (reached $4 billion+ valuation) and Outreach (reached $4 billion+ valuation).
Includes over 10 late stage Artificial Intelligence or AI related companies with annual revenues averaging over $100 million.
Advisory board competitive advantage:
70+ members provide critical/proprietary diligence insights, guidance, deal access, advantage and counsel on investment decisions. E.g. Ex Spirit Airlines CEO, Ex Peabody Energy COO, Ex Weight Watchers CFO, Ex Yahoo CFO, co-developer Lipitor (a top selling drug of all time), Harvard professor, heads of VC funds, founder WordPress, Shark Tank judge, artificial intelligence industry leaders (from Stripe, DataRobot, others), ex Goldman Sachs bankers etc.
Other investors in our portfolio companies:
Softbank, Elon Musk, Goldman Sachs, Morgan Stanley, Fidelity, Kleiner Perkins, Koch Industries, Salesforce.com, Sequoia, Tiger, Google Ventures, Andreessen Horowitz, Softbank, Bain Capital, American Express, HSBC, Benchmark, and others.
Liquidity anticipated horizon:
Anticipated capital returns commence within an estimate of one to three years of investment.
Core industries of interest:
AI, B2B SaaS, Semiconductors, software, life sciences, alternative energy, industrial, and consumer. Targets: Revenues (recent year) >$100 million, Revenue recurrence > 80%, Growth > 30%, Gross margins > 75%, Profitability: Current or visible.
Sector return news:
Secondaries investments have historically achieved similar IRR with lower volatility than primary private equity transactions (Goldman Sachs 12/22).
To learn more about CrossWork's signature pre-IPO Midas Fund, review detailed fund information. 
